Audiobook
About this episode
Sickle cell disease is an inherited disorder affecting the blood. Recently, promising new treatment strategies have emerged involving gene editing therapies and the administration of stem cells directly into the developing foetus in the womb. Along with his colleagues, Dr Panicos Shangaris at Kings College London, has conducted a comprehensive review of the available evidence to support this novel approach.
Original Article Reference
This SciPod is a summary of the paper ‘In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System’, from Frontiers in Cell and Developmental Biology. DOI: https://doi: 10.3389/fcell.2020.624477
This work is licensed under a Creative Commons Attribution 4.0 International License.
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.